![](/img/cover-not-exists.png)
The FXR agonist GS-9674 reduces fibrosis and portal hypertension in a rat model of NASH
Schwabl, P., Budas, G., Hambruch, E., Supper, P., Burnet, M., Liles, J., Sullivan, T., Huntzicker, E., Birkel, M., French, D., Tumas, D., Peck-Radosavljevic, M., Watkins, W., Trauner, M., BreckenridgeVolume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)31190-5
Date:
April, 2018
File:
PDF, 89 KB
english, 2018